In hepatocellular carcinoma (HCC) patients, circulating levels of syndecan‐1 [252], glypican‐3 [45, 252, 260, 261], and endocan [262, 263] were higher than patients with liver fibrosis/cirrhosis, chronic hepatitis or healthy controls. The gene discussed is ESM1; the disease is hepatocellular carcinoma.